AU2006341592A1 - Intramuscular antiviral treatments - Google Patents

Intramuscular antiviral treatments Download PDF

Info

Publication number
AU2006341592A1
AU2006341592A1 AU2006341592A AU2006341592A AU2006341592A1 AU 2006341592 A1 AU2006341592 A1 AU 2006341592A1 AU 2006341592 A AU2006341592 A AU 2006341592A AU 2006341592 A AU2006341592 A AU 2006341592A AU 2006341592 A1 AU2006341592 A1 AU 2006341592A1
Authority
AU
Australia
Prior art keywords
nhcoch
compound
formula
nhcoch3
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006341592A
Other languages
English (en)
Inventor
Shane Arnold
Yarlagadda S. Babu
Shanta Bantia
Pooran Chand
John Michael Kilpatrick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocryst Pharmaceuticals Inc
Original Assignee
Biocryst Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocryst Pharmaceuticals Inc filed Critical Biocryst Pharmaceuticals Inc
Publication of AU2006341592A1 publication Critical patent/AU2006341592A1/en
Assigned to BIOCRYST PHARMACEUTICALS, INC. reassignment BIOCRYST PHARMACEUTICALS, INC. Request for Assignment Assignors: ARNOLD, SHANE, BABU, YARLAGADDA, BANTIA, SHANTA, BIOCRYST PHARMACEUTICALS, INC., CHAND, POORAN, KILPATRICK, JOHN
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU2006341592A 2006-04-12 2006-04-12 Intramuscular antiviral treatments Abandoned AU2006341592A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/013535 WO2007117241A1 (en) 2006-04-12 2006-04-12 Intramuscular antiviral treatments

Publications (1)

Publication Number Publication Date
AU2006341592A1 true AU2006341592A1 (en) 2007-10-18

Family

ID=37671157

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006341592A Abandoned AU2006341592A1 (en) 2006-04-12 2006-04-12 Intramuscular antiviral treatments

Country Status (8)

Country Link
JP (1) JP2009533428A (ru)
CN (1) CN104784166A (ru)
AU (1) AU2006341592A1 (ru)
BR (1) BRPI0621552A2 (ru)
CA (1) CA2649090A1 (ru)
EA (1) EA200870430A1 (ru)
MX (1) MX2008013140A (ru)
WO (1) WO2007117241A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0518443D0 (en) 2005-09-09 2005-10-19 Evolutec Ltd Method of treating myasthenia gravis
CN101367750B (zh) * 2007-08-14 2012-05-23 中国人民解放军军事医学科学院毒物药物研究所 (1s,2s,3s,4r)-3-[(1s)-1-乙酰氨-2-乙基-丁基]-4-胍基-2-羟基-环戊基-1-羧酸水合物及其医药用途
AU2011204483B2 (en) * 2010-01-08 2016-02-11 Volution Immuno Pharmaceuticals Sa EV576 for use in the treatment of viral infections of the respiratory tract
CN102584637B (zh) * 2011-01-17 2014-07-09 天津药物研究院 帕拉米韦水合物晶体、制备方法、药用组合物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1282316A (zh) * 1997-12-17 2001-01-31 生物晶体药品股份有限公司 用作神经氨酸酶抑制剂的取代环戊烷和环戊烯化合物
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments

Also Published As

Publication number Publication date
EA200870430A1 (ru) 2009-06-30
WO2007117241A1 (en) 2007-10-18
BRPI0621552A2 (pt) 2011-12-13
MX2008013140A (es) 2009-02-12
CN104784166A (zh) 2015-07-22
JP2009533428A (ja) 2009-09-17
CA2649090A1 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
JP2009545541A (ja) カチオン界面活性剤の抗ウイルスのための使用
JPWO2008108323A1 (ja) インフルエンザ治療剤
US20220040137A1 (en) Antiviral treatments
AU2006341592A1 (en) Intramuscular antiviral treatments
AU2012328343A1 (en) Compounds for the treatment of influenza
AU2013216632B2 (en) Intravenous antiviral treatments
US20070244193A1 (en) Intramuscular antiviral treatments
JP2009538822A5 (ru)
KR20080113099A (ko) 근육내 항바이러스 치료
AU2016262644B2 (en) Intravenous antiviral treatments

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: BIOCRYST PHARMACEUTICALS, INC.

Free format text: FORMER APPLICANT(S): KILPATRICK, JOHN; CHAND, POORAN; BANTIA, SHANTA; ARNOLD, SHANE; BABU, YARLAGADDA; BIOCRYST PHARMACEUTICALS, INC.

MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application